Medication Safety
Featured Article
Ascend Laboratories is recalling nine lots of cephalexin for oral suspension because impurity results during testing were “at [the] higher side of the specification limit.”
Damon Birkemeier, PharmD, FDA/ISMP safe medication management fellow, discusses survey results concerning compounding technologies and common safety errors, as well as some of the biggest perceived…
Two batches of enoxaparin sodium injections are being recalled by Apotex Corp. because of incorrect dosage markings on some syringe barrels.